Abu Dhabi Inaugurates State-of-the-Art Biobank to Transform Healthcare
April 4, 2026
Abu Dhabi Inaugurates State-of-the-Art Biobank to Transform Healthcare iamge

Abu Dhabi has taken a major step toward transforming how disease is detected, prevented, and treated with the inauguration of the Abu Dhabi Biobank — a groundbreaking platform that connects biological samples with genomic, lifestyle, and clinical data to enable earlier action and more personalised care. Abu Dhabi Media Office This landmark development marks a turning point not just for the UAE, but for healthcare systems across the Middle East and beyond, setting a new global standard in precision medicine and data-driven health management.

In a world where chronic diseases are rising, populations are ageing, and medical systems face increasing pressure, the need for smarter, more proactive healthcare has never been greater. The Abu Dhabi Biobank answers this call directly — combining the power of cutting-edge biology, artificial intelligence, and real-world health data into one unified, living platform that promises to change the way communities understand and manage their health.

A Strategic Partnership Driving Innovation

Developed through a strategic partnership between the Department of Health – Abu Dhabi (DoH) and M42, the biobank reflects a fundamental shift in how healthcare is delivered — moving away from treating disease after it occurs, toward identifying risk earlier, improving diagnosis, and tailoring interventions to the individual. Abu Dhabi Media Office

This collaboration brings together the regulatory authority and vision of the DoH with the technological and operational capabilities of M42, a globally recognised health technology powerhouse. Together, they have created an infrastructure that not only serves Abu Dhabi’s population today but is designed to grow and evolve as medical science advances. The partnership signals a bold commitment from Abu Dhabi’s leadership to position the emirate at the forefront of global health innovation.

A World-Class Facility Built for the Future

Located in Masdar City, the net-zero, state-of-the-art facility is equipped to store over 100,000 cord blood samples and up to five million biological samples, positioning it among the region’s most advanced repositories of health data. GCC Business News

The choice of Masdar City — Abu Dhabi’s hub for sustainable innovation — is itself significant. The Abu Dhabi Biobank is the UAE’s first net-zero biobank, powered largely by solar energy, designed to minimise its carbon footprint and serve as a model of eco-friendly innovation. Abudhabibiobank This reflects a broader understanding that the future of healthcare must also be the future of sustainability — that caring for human health and caring for the planet are not competing priorities but deeply connected ones.

The facility is built not simply as a storage unit, but as a dynamic, intelligent ecosystem. Beyond its storage capacity, the platform introduces an integrated model that connects biology, clinical practice, and real-world data at scale, supporting improved patient outcomes and system-wide efficiency. GCC Business News

Two Major Capabilities Launched

The launch introduces two major capabilities: a pan-human biobank that links biological samples with longitudinal clinical, genomic, and lifestyle data at scale, and a national eye bank that strengthens local transplantation capabilities and reduces reliance on imported tissue. Zawya

The pan-human biobank is particularly significant. By collecting and linking data across multiple dimensions — genetics, lifestyle choices, environmental factors, and clinical history — it enables a level of health insight that was previously impossible. Doctors and researchers will be able to identify patterns across large populations, discover new risk factors for disease, and develop treatments that are far more targeted and effective than current approaches allow.

The national eye bank, meanwhile, addresses a critical gap in the UAE’s healthcare system. By building local capacity for tissue storage and transplantation, Abu Dhabi reduces its dependence on overseas supply chains for eye tissue — ensuring faster access to treatment for patients who need corneal transplants and other eye-related procedures.

Transforming Healthcare for Residents

Through the Abu Dhabi Biobank, residents will benefit from earlier detection of disease risk, more accurate diagnoses, and treatments better tailored to their individual biology. It also enables individuals to contribute to research that will benefit future generations. Gulf News

This is not healthcare as a passive experience — it is healthcare as active participation. Residents who contribute their biological samples to the biobank become part of something much larger than their own individual care. They become contributors to a shared scientific resource that will help doctors understand diseases more deeply, develop new therapies, and ultimately save lives across generations.

Drawing on a population representing more than 200 nationalities, the biobank enables insights that are more reflective of real-world diversity, helping improve the relevance and effectiveness of medical innovation. Gulf News In a world where much medical research has historically been conducted on narrow demographic groups, this diversity is a genuine scientific asset — one that will make the findings emerging from Abu Dhabi’s biobank more universally applicable and more equitable in their impact.

Leadership Vision

Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated that healthcare is moving from reacting to disease to anticipating and preventing it, and that the Abu Dhabi Biobank enables this shift by connecting data, science, and care in a way that directly improves people’s lives — detecting risks earlier, personalising treatment, and delivering better outcomes for the community while contributing to global progress in medicine. GCC Business News

Dimitris Moulavasilis, Group CEO of M42, described the Abu Dhabi Biobank as a critical step in building a health system that is more proactive, precise, and data-driven — one that brings together biological samples, AI, genomics, and real-world data to enable faster insights, better decisions, and ultimately improved outcomes at scale. Doh

The inauguration was attended by senior leadership including H.E. Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, alongside representatives from leading healthcare providers, research institutions, academia, and global industry partners. Doh

Conclusion

The inauguration of the Abu Dhabi Biobank is far more than a healthcare milestone — it is a declaration of intent. Abu Dhabi is signalling to the world that the future of medicine will be built on data, diversity, and deep scientific collaboration. By investing in a facility that links millions of biological samples with genomic and clinical intelligence, the emirate is laying the foundation for a healthcare system that is not only more effective but more humane — one that sees patients not as cases to be treated, but as individuals whose unique biology deserves to be understood. As this living platform grows and evolves, it holds the potential to unlock discoveries that will benefit not just the people of Abu Dhabi, but patients and communities around the world for decades to come.